The sector of stem cell therapy is experiencing rapid growth, attracting both considerable investment and heightened public scrutiny. This multifaceted financial landscape is influenced by a spectrum of factors, including governmental frameworks, research costs, and the dynamic demands of the patient population. Deciphering this terrain is crucial

Glaucoma, a condition that damages the optic nerve and can lead to vision loss, often requires surgical intervention. Fortunately, minimally invasive glaucoma surgery (MIGS) offers a less disruptive alternative to traditional procedures. These approaches involve small incisions and minimal tissue manipulation, resulting in quicker recovery times, r